Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ]: Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Thu, February 16, 2012
Wed, February 15, 2012
Tue, February 14, 2012
Mon, February 13, 2012
Sun, February 12, 2012
Fri, February 10, 2012

Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors


//health-fitness.news-articles.net/content/2012/ .. ppoints-alison-lawton-to-board-of-directors.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--[ Cubist Pharmaceuticals, Inc. ] (NASDAQ: CBST) today announced the appointment of Alison Lawton to its Board of Directors. Ms. Lawton is currently Senior Vice President, General Manager Biosurgery, at Genzyme Corporation (now part of Sanofi). With the addition of Ms. Lawton, the Cubist Board of Directors consists of 10 members, nine of whom are independent.

"As we prepare for future product launches on a global scale, Alisonas counsel will be invaluable to the Company."

aAlisonas tremendous breadth and depth of experience in international regulatory affairs and operations adds an important and complementary skill set to the Cubist Board,a said Kenneth Bate, non-executive Chairman of the Board of Directors of Cubist. aAs we prepare for future product launches on a global scale, Alisonas counsel will be invaluable to the Company.a

Ms. Lawton joined Genzyme in 1991 as an international regulatory affairs specialist. As head of Genzyme Biosurgery, Ms. Lawton is responsible for Genzymeas global orthopedics, biosurgical specialty (BSS) and cell therapy and regenerative medicine (CT&RM) businesses. The orthopedic business includes the Synvisc and Jonexa franchises; the BSS business consists of Seprafilm; and the CT&RM products include the autologous cell therapies Carticel, MACI and Epicel. Prior to this role, Ms. Lawton oversaw Global Market Access at Genzyme, which included Regulatory Affairs, Global Health Outcomes and Strategic Pricing, Global Public Policy and Global Product Safety & Risk Management. Before joining Genzyme, Ms. Lawton worked for seven years at Parke-Davis in the United Kingdom. She has a bacheloras degree in Pharmacology from the University of London.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubistas web site at [ www.cubist.com ].


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear